Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
Gladstone Press Room
Find the latest news, high-quality multimedia, and expert contacts to ensure accurate and impactful storytelling. Our media team is here to assist you.
Media Contacts
Kelly Quigley
Director of Science Communications & Media Relations
kelly.quigley@gladstone.ucsf.edu
Julie Langelier
Director, Strategic Communications and Creative Operations
julie.langelier@gladstone.ucsf.edu
Sign Up to Receive Press Releases
Be the first to know about new scientific findings and other announcements from Gladstone.
Latest News
Read
Read
In Alzheimer’s Disease, the Brain’s Pacemaker Cells Lose Their Beat
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain…
Read
Gladstone Institutes Launches Redesigned Website, Bringing Cutting-Edge Biomedical Research Into Focus
Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
Read
Newly Discovered Antiviral System in Bacteria Is ‘Strangest of Its Kind’
The complex Rube Goldberg-like molecular machinery could inspire novel technology to study and treat disease.
Read
Gladstone’s Seth Shipman Named Fellow of the California Academy of Sciences
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
Read
Novel Biosensor Uses DNA ‘Barcodes’ to Uncover Disease Signals in Cells
Inspired by bacterial biology, the Gladstone-developed “Detectron” opens up new possibilities for disease research and potentially treatments.
Read
How a Single Viral Protein Hijacks Immune Cells to Supercharge COVID-19 Infection
A new discovery reveals how a SARS-CoV-2 protein reprograms immune cells to accelerate viral spread—and points to a new strategy…
Read
Rethinking ‘Exhausted’ T Cells: Gilbert Herrera Named Inaugural Ellen & Bernard Marson Fellow
The fellowship provides three years of funding for graduate students pursuing groundbreaking immunology research.
Read
The 2026 Ogawa-Yamanaka Stem Cell Prize Awarded to Jun Takahashi
Takahashi is recognized for his pioneering work translating iPS cell technology into a clinically approved therapy for Parkinson’s disease.
Read
Scientists Decode Gene Circuits of Human Immunity, Fueling New Era of Disease Research
An unprecedented map of 22 million immune cells provides the functional rulebook for virtual biology and next-generation immunotherapies.
Connect With an Expert
Gladstone’s investigators are at the forefront of biomedical research, covering a wide range of critical and emerging fields.
Trending Topics
- H5N1 Bird Flu
- Measles Outbreaks
- AI for Drug Discovery
- Drug Resistant Infections
- Advances in Alzheimer’s Research
- Stem Cells to Repair the Heart
All Areas of Expertise
- Alzheimer’s and Other Dementias
- Antibiotic Resistance
- Artificial Intelligence for Drug Discovery
- Autoimmune Diseases
- Cancer
- COVID-19 and Long COVID
- CRISPR Genome Editing
- Heart Disease
- HIV/AIDS
- Multiple Sclerosis
- Stem Cells and Regenerative Medicine
- Traumatic Brain Injury
- Vaccines
- Viruses and Infectious Diseases
Our Experts
Deepak Srivastava, MD
Gladstone President
Deepak Srivastava is president of Gladstone Institutes. He is also the Younger Family Professor and a senior investigator at the Gladstone Institute of Cardiovascular Disease, and director of the Roddenberry Stem Cell Center.
Talk to Deepak about:
- Stem cells for curative therapies
- Artificial intelligence for drug discovery and development
- Latest discoveries for heart health
Benoit Bruneau, PhD
Senior Investigator and Director, Gladstone Institute of Cardiovascular Disease
Steve Finkbeiner, MD, PhD
Senior Investigator and Director, Gladstone Center for Systems and Therapeutics
Alex Marson, MD, PhD
Senior Investigator and Director, Gladstone-UCSF Institute of Genomic Immunology
Lennart Mucke, MD
Senior Investigator and Director, Gladstone Institute of Neurological Disease
Melanie Ott, MD, PhD
Senior Investigator and Director, Gladstone Infectious Disease Institute
Katie Pollard, PhD
Senior Investigator and Director, Gladstone Institute of Data Science and Biotechnology
Facts and Figures
Research Labs
Years of disease-driven research
Scientists
Institutes
Gladstone Institutes is an independent, nonprofit research organization driving a new era in biomedical innovation—an era in which it’s possible to contemplate cures, not just treatments.
Media Assets
For specific assets not provided here, submit a request with our media relations team.
Featured Videos
Read
Science in Seconds | An Unprecedented Map of Human Immune Cells
In this video, Gladstone scientists Emma Dann and Ronghui Zhu explain how their new study offers a powerful framework for…
Read
This Is AI Designing Its Own Experiments
Gladstone scientists have developed a thinking microscope powered by artificial intelligence.
Read
This Is AI Predicting New Ways to Treat Disease
How do brain cells change with age? How are liver cells impacted when someone takes a new medicine? What happens…
Read
This Is AI Decoding the Genetic Cause of Disease
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in…
Read
Science in Seconds | A New Path Toward Life Without Daily HIV Pills
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the…
Get Involved
Join the Team
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsPartner With Us
Discoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreGive
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now